Scientists have created the first detailed day-by-day map of human embryo development using single-cell technology.

Symptomatic or viral rebound is estimated to occur in 0.8% to 32% of Paxlovid recipients and 1.1% to 31% of those who receive ...

Avak Kahvejian, PhD, a general partner with biotech incubator Flagship Pioneering, discusses how AI is rearchitecting methods ...

Scientists announced the Biodiversity Cell Atlas project to map every cell type across all eukaryotic life on Earth.

It's no secret that we need new ways to treat and detect disease, including cancer. Specifically, we need better biomarkers ...

For the first time, scientists can view RNA molecules directly inside cells and tissue in minute detail and across the entire ...

Bioengineers at the University of California San Diego have developed a powerful new technology that can map the entire ...

A new study has identified a promising drug target for a common chronic illness that could shield insulin-producing cells ...

(WBL), a Renew Biotechnologies subsidiary, and the largest U.S. sequencing service provider dedicated exclusively to ...

Discover Daiichi Sankyo's Q2 2024 earnings, updated revenue forecasts, oncology pipeline advances, and global partnerships.

Introduction Only symptomatic treatments are available for patients with Parkinson’s disease (PD), the second most common chronic neurodegenerative disease worldwide, and it is therefore imperative to ...